- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
The role of intermittent androgen suppression in biochemically recurrent or newly diagnosed metastatic prostate cancer - Abstract
September 11, 2013
Phase II trial of zoledronic acid combined with androgen-deprivation therapy for treatment-naïve prostate cancer with bone metastasis - Abstract
September 11, 2013
Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty - Abstract
September 11, 2013
Magnetic resonance imaging-guided cryoablation of recurrent prostate cancer after radical prostatectomy: Initial single institution experience - Abstract
September 11, 2013
Dosimetric quality and evolution of edema after low-dose-rate brachytherapy for small prostates: Implications for the use of newer isotopes - Abstract
September 11, 2013
Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation - Abstract
September 11, 2013
Qualitative systematic review of barber-administered health education, promotion, screening and outreach programs in African-American communities - Abstract
September 11, 2013
Determinants of the combined use of external beam radiotherapy and brachytherapy for low-risk, clinically localized prostate cancer - Abstract
September 11, 2013
Pleuropulmonary and lymph node progression after docetaxel - Benefits from treatment with cabazitaxel in metastatic prostate cancer - Abstract
September 10, 2013
Prostate cancer with metastases to the kidney: A rare manifestation of a common disease - Abstract
September 10, 2013
Hybrid multidimensional T(2) and diffusion-weighted MRI for prostate cancer detection - Abstract
September 10, 2013
Predicting the risk of bone metastasis in prostate cancer - Abstract
September 10, 2013